(Date:5/9/2008)... TUSTIN, Calif., May 9 /PRNewswire-FirstCall/ --...ally integrated specialty pharmaceutical company,w...ubsidiary, Jade,Pharmaceutical Inc., today announc...the year ended December 31, 2007, which were inclu...he Securities and Exchange,Commission on April 14,...
(Date:5/9/2008)... First Medication Indicated for Maintenance T...e-FirstCall/ -- Eli Lilly and Company,(NYSE: LLY ...Drug,Administration (FDA) has approved Strattera(R...ttention-Deficit/Hyperactivity Disorder (ADHD) in,...orepinephrine reuptake,inhibitor, is the first FDA...
(Date:5/9/2008)... SAN DIEGO, May 9 /PRNewswire/ -- Summary: With ...an estimated 100,000 deaths and leaving over a,mil...mmense. Internet,entrepreneurs Sharon Tucci and St...rassroots effort to award awareness for humanitari...s possible. Setting an initial goal,of having 1,00...
(Date:5/9/2008)... EVANSTON, Ill., May 9 /PRNewswire-USNewswire/ -... effort to help relieve the unspeakable human,suff...ecial donation kiosks,have been developed and are ...ual world of Second Life, with coordination being ... main island,( http://slurl.com/secondlife/Simuali...
Breaking Medicine News(10 mins):Health News:AMDL Reports Going Concern Qualification 2Health News:FDA Approves Strattera(R) for Maintenance of ADHD in Children and Adolescents 2Health News:FDA Approves Strattera(R) for Maintenance of ADHD in Children and Adolescents 3Health News:FDA Approves Strattera(R) for Maintenance of ADHD in Children and Adolescents 4Health News:FDA Approves Strattera(R) for Maintenance of ADHD in Children and Adolescents 5Health News:FDA Approves Strattera(R) for Maintenance of ADHD in Children and Adolescents 6Health News:New Web Site to Raise Awareness for the Myanmar Crisis Has Lofty Goals 2...nning on launching a program to improve the care, ...dren in Zimbabwe//, where one child dies of AIDS a...ement Wednesday, UNICEF Britain has acknowledged t...tening Zimbabwe's children and has given UNICEF ?2...
...of the world's largest and leading confectionery m...n business, Monkhill//. It is basically a London ... dispose off its non-core assets. The sale of Mo...our manufacturing plants and one distribution depo...
...eservation of postgraduate medical seats to in-ser...Tuesday the Government announced that these candid...mum specified period upon completion of the PG deg...y a default fine of Rs 20 lakhs. The government’s...
...rsed the new Medicare prescription drug benefit an... up before the May 15 deadline. // "It doesn't cos... said Bush. "Seniors are saving about half on thei...you're a poor senior, the government is going to p...
Other Medicine News:Health News:UNICEF To Launch A Programme For Zimbabwe Children 2(Date:5/8/2008)...- Alpharma Inc. (NYSE: ALO ),a global specialty ...om,clinical trials that showed ALO-01 (EMBEDA(TM))...ed naltrexone hydrochloride) capsules,demonstrated...bility,alongside a promising safety and efficacy p...he 27th Annual Scientific Session of the American,...
(Date:5/8/2008)...herapeutic Proteins at Tumor,Site, ARLINGTON HE...g gene,therapy, plastic surgeons have delivered ca...n cancerous tumors on rats with a 79 percent reduc...May issue of Plastic and,Reconstructive Surgery(R)...iety of Plastic Surgeons (ASPS). This new delivery...
(Date:5/8/2008)...f the American Pain Society ...-- Patients treated with lacosamide,demonstrated s...n (DNP),compared to placebo-treated patients, acc...g of the American Pain Society (APS) in Tampa, Fla... a diabetic neuropathic,pain treatment providing e...
(Date:5/8/2008)...stigators to Assess BSI-201 Therapy in B... Calif., May 8 /- BiPar Sciences, Inc...l trial programs for its lead,product, BSI-201, in...trial,of BSI-201 that BiPar has launched in the pa...t and brain cancer., The company is evaluating BS...
Breaking Medicine Technology:Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 2Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 3Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 4Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 5Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 6Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 7Skin Flaps Deliver Cancer-fighting Therapy, ASPS Study Reveals 2Skin Flaps Deliver Cancer-fighting Therapy, ASPS Study Reveals 3New Lacosamide Data Provides Evidence for Long-Term Efficacy in Diabetic Neuropathic Pain 2New Lacosamide Data Provides Evidence for Long-Term Efficacy in Diabetic Neuropathic Pain 3New Lacosamide Data Provides Evidence for Long-Term Efficacy in Diabetic Neuropathic Pain 4BiPar Sciences Expands Phase 2 Clinical Trials of BSI-201, a Novel DNA Repair Inhibitor, in Ovarian Cancer 2Crystal Research Associates LLC Issues Executive Informational Overview 28R 29 28EIO 28R 29 29 on Tapestry Pharmaceuticals Inc 973 1Crystal Research Associates LLC Issues Executive Informational Overview 28R 29 28EIO 28R 29 29 on Tapestry Pharmaceuticals Inc 973 2Crystal Research Associates LLC Issues Executive Informational Overview 28R 29 28EIO 28R 29 29 on Tapestry Pharmaceuticals Inc 973 3CryoCor Invited to Participate in FDA Advisory Panel Meeting on Atrial Fibrillation 969 1CryoCor Invited to Participate in FDA Advisory Panel Meeting on Atrial Fibrillation 969 2Novel Angiogenic Drugs Including a Future Blockbuster from Genzyme Could Revolutionize Treatment of Peripheral Arterial Disease 492 1Novel Angiogenic Drugs Including a Future Blockbuster from Genzyme Could Revolutionize Treatment of Peripheral Arterial Disease 492 2Sinovac Commences Vaccination on Volunteers for Phase II Clinical Trial on Pandemic Influenza H5N1 Vaccine 242 1Sinovac Commences Vaccination on Volunteers for Phase II Clinical Trial on Pandemic Influenza H5N1 Vaccine 242 2...SINESS WIRE)--Apr 26, 2007 - A new study published...ology indicates,that a treatment from Medtronic, I...rebral palsy improves their quality of life and is...-effective,treatments. The findings of this Medtro...eatment, known as Medtronic ITB Therapy(SM),(Intra...
...idence for the Effectiveness of Hypertension,Treat... in Japanese,Patients, TOKYO, April 26, 2007 /Xinh...EI HEART Study, the large-scale clinical trial,hea...s today,published in the internationally renowned ...ore than 3,000 patients, is one of,the largest car...
Other Medicine Technology:Study Supports Cost-Effectiveness of Medtronic's Spasticity,Treatment for Children with Cerebral Palsy 2Study Supports Cost-Effectiveness of Medtronic's Spasticity,Treatment for Children with Cerebral Palsy 3Study Supports Cost-Effectiveness of Medtronic's Spasticity,Treatment for Children with Cerebral Palsy 4First Controlled Large-Scale Intervention Angiotensin Receptor,Blocker (ARB) Trial in a Japanese Population, JIKEI HEART Study,Demonstrates Significant Reduction in Blood Pressure and Protection,of Organs with Valsartan 2First Controlled Large-Scale Intervention Angiotensin Receptor,Blocker (ARB) Trial in a Japanese Population, JIKEI HEART Study,Demonstrates Significant Reduction in Blood Pressure and Protection,of Organs with Valsartan 3First Controlled Large-Scale Intervention Angiotensin Receptor,Blocker (ARB) Trial in a Japanese Population, JIKEI HEART Study,Demonstrates Significant Reduction in Blood Pressure and Protection,of Organs with Valsartan 4FalciVax is a two site sandwich immunoassay utilizing whole blood for the detection of P. falciparum specific histidine rich protein-2 (Pf. HRP-2) and P. vivax specific pLDH. The test can also be use
The Cellabs Rapimal (P.f.) is a rapid and sensitive in vitro immunochromatography assay system for the detection of HRP-2 antigen produced by P. falciparum at the merozoite (red blood cell) stage o
An immunochromatographic rapid test for the detection of Plasmodium falciparum in whole blood.
Malaria device / strip (3 line, P.f/P.v Ag Test-pLDH)
Medicine Products: